Melatonin has therapeutic potential in DN by preventing inflammation, and fibrosis reduces inflammation and fibrosis in DN through TLR4, i.e., the TGF-β1/Smad3 signaling pathway (25). This evidence concerns the gene TGFB1 and liver dysplastic nodule.